Source:
Wall Street JournalWSJ: Clinton Foundation Sets Up Malaria-Drug Price Plan
Aim Is to Stabilize Fluctuating Prices, Boost Availability
By MARK SCHOOFS
July 17, 2008; Page A8
Former President Bill Clinton's foundation is set to unveil a pricing agreement Thursday that it hopes will make malaria drugs available to millions of poor people. The agreement points to the sophistication needed to harness market forces and get lifesaving medicines to countries where treatable diseases still take a staggering toll.
First-line malaria drugs -- known as ACTs, for artemisinin-based combination therapies -- present a tricky problem: the volatile cost of the powerful antimalarial plant extract artemisinin. During the past few years, the price of that key ingredient has fluctuated from as little as $150 a kilogram to as much as $1,100, according to Chinese producers.
Such instability makes it difficult for those in the market -- from artemisinin producers to pharmaceutical companies to the health ministries that often buy the drugs -- to plan. That can make pharmaceutical companies wary of reducing prices for fear of another price spike and deter generic-drug makers from entering the market and fostering more-competitive pricing.
The agreement Mr. Clinton plans to announce aims to limit price fluctuations. It creates a consortium of two Chinese raw-artemisinin suppliers, two Indian companies that convert artemisinin into the active pharmaceutical ingredient and two Indian generic-drug companies. Among other things, the deal puts a ceiling on the price of the raw artemisinin in return for a guarantee that other consortium members will purchase large proportions of their artemisinin from the two participating suppliers, unless nonmembers can offer equal-quality product at an undisclosed discount....
Read more:
http://online.wsj.com/article/SB121626447476161201.html?mod=todays_us_page_one